Qian Yuan Baixing, Inc (QYBX) Fair Value & Analysis
Consumer Cyclical · US · Market cap $559K
Qian Yuan Baixing, Inc
QYBX · US
Fair value as of: Aug 2, 2026
From 7 valuation models · updated 8 days ago
Fair value updated Aug 2, 2026, revised from $0.0065 to $0.0075 (+15.9%) since Jun 26, 2026. Share price +55.0% over the past month.
Below-average quality, and screening another 19% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($0.0075). The favourable scenario is already priced in.
- Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The models converge in a tight band ($0.0070 to $0.0075), unusually little disagreement for a valuation.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 2, 2026.
How to read this chart
60‑month range $0.0006 – $0.1144 · fair‑value band $0.0070 – $0.0075 · the $0.0093 price screens above the $0.0075 fair value. Dashed = 300-day average. As of Aug 2, 2026.
Analysis
Qian Yuan Baixing, Inc (QYBX) currently trades at $0.0093, while our model-based Fair Value estimate is $0.0075, implying the stock looks roughly 19.4% overvalued today. The Quality Score stands at 42/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Qian Yuan Baixing, Inc generated revenue of $12.9M at a net margin of -4.5%. Revenue declined 20.8% year over year. The balance sheet holds a net cash position of $1.3M. Fundamentals as of Aug 2, 2026
Our scenario range runs from $0.0070 (bear case) to $0.0075 (bull case); at $0.0093, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 35% below its 52-week high and 158% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -49% fair-value upside, at -19%, QYBX screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 7 models by family
Widest divergence: DCF Models ($0.0600) versus Asset-Based ($0.0100). Highest evidence: P/E Multiple (63).
Notify me when QYBX reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 2, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 49 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Qian Yuan Baixing, Inc. focuses on the medical equipment diagnostic and biotech business. The company was formerly known as MDCorp. and changed its name to Qian Yuan Baixing, Inc. in May 2018. Qian Yuan Baixing, Inc. was founded in 2005 and is based in Seattle, Washington.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Qian Yuan Baixing, Inc reported revenue of $2.3M in FY2025 versus $181K in FY2021, a compound +89.0%/yr. Reported net income was $127K in FY2025, compounding +18.9%/yr from FY2021.
QYBX screens 19% overvalued. Compare with Amazon.com, Inc →
Peer Group
Internet Retail · 109 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Internet Retail median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Internet Retail stocks, each showing price versus our Fair Value estimate (as of Aug 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Amazon.com, Inc AMZN | $245.34 | $127.67 | -48% |
| Alibaba Group BABA | $114.97 | $75.75 | -34% |
| PDD Holdings PDD | $84.14 | $223.51 | +166% |
| MercadoLibre, Inc MELI | $1,814 | $798.98 | -56% |
| DoorDash, Inc DASH | $190.16 | $38.64 | -80% |
| Sea Limited SE | $106.22 | $52.70 | -50% |
| eBay Inc EBAY | $117.20 | $60.13 | -49% |
| JD.com, Inc JD | €25.95 | €31.88 | +23% |
| Coupang, Inc CPNG | $16.86 | $2.79 | -83% |
| Delivery Hero SE DHER | €38.18 | €12.71 | -67% |
Compare Qian Yuan Baixing, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Qian Yuan Baixing, Inc (QYBX) overvalued or undervalued?
What is the fair value of QYBX?
What is the quality score of QYBX?
What is the revenue of Qian Yuan Baixing, Inc (QYBX)?
What is the net profit margin of QYBX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Qian Yuan Baixing, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.